ATOS — Atossa Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapMomentum Trap
- $123.45m
- $20.16m
- 40
- 37
- 69
- 47
Annual cashflow statement for Atossa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.4 | -17.2 | -17.8 | -20.6 | -27 |
| Depreciation | |||||
| Non-Cash Items | 2.3 | 8.63 | 6.43 | 4.83 | 7.12 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.095 | -0.57 | -0.216 | -0.719 | -0.928 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.96 | -9.13 | -11.6 | -16.5 | -20.8 |
| Capital Expenditures | -0.111 | -0.008 | -0.009 | -0.009 | -0.027 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -4.7 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.111 | -0.008 | -0.009 | -0.009 | -4.73 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 12.3 | 11.3 | 38.6 | 113 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.22 | 2.2 | 27 | 96.8 | -25.5 |